1. Home
  2. RGEN vs DUOL Comparison

RGEN vs DUOL Comparison

Compare RGEN & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • DUOL
  • Stock Information
  • Founded
  • RGEN 1981
  • DUOL 2011
  • Country
  • RGEN United States
  • DUOL United States
  • Employees
  • RGEN N/A
  • DUOL N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • DUOL Computer Software: Prepackaged Software
  • Sector
  • RGEN Health Care
  • DUOL Technology
  • Exchange
  • RGEN Nasdaq
  • DUOL Nasdaq
  • Market Cap
  • RGEN 7.6B
  • DUOL 14.9B
  • IPO Year
  • RGEN N/A
  • DUOL 2021
  • Fundamental
  • Price
  • RGEN $156.55
  • DUOL $312.52
  • Analyst Decision
  • RGEN Buy
  • DUOL Buy
  • Analyst Count
  • RGEN 12
  • DUOL 12
  • Target Price
  • RGEN $187.44
  • DUOL $362.67
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • DUOL 484.1K
  • Earning Date
  • RGEN 02-19-2025
  • DUOL 02-26-2025
  • Dividend Yield
  • RGEN N/A
  • DUOL N/A
  • EPS Growth
  • RGEN N/A
  • DUOL N/A
  • EPS
  • RGEN N/A
  • DUOL 1.83
  • Revenue
  • RGEN $633,513,000.00
  • DUOL $689,459,000.00
  • Revenue This Year
  • RGEN $2.28
  • DUOL $42.79
  • Revenue Next Year
  • RGEN $9.88
  • DUOL $29.76
  • P/E Ratio
  • RGEN N/A
  • DUOL $171.00
  • Revenue Growth
  • RGEN N/A
  • DUOL 42.47
  • 52 Week Low
  • RGEN $113.50
  • DUOL $145.05
  • 52 Week High
  • RGEN $211.13
  • DUOL $378.48
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • DUOL 38.46
  • Support Level
  • RGEN $149.15
  • DUOL $305.01
  • Resistance Level
  • RGEN $160.64
  • DUOL $347.04
  • Average True Range (ATR)
  • RGEN 5.96
  • DUOL 12.00
  • MACD
  • RGEN 0.91
  • DUOL -3.07
  • Stochastic Oscillator
  • RGEN 79.57
  • DUOL 17.87

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include The Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has three predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test.

Share on Social Networks: